Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-003245
Filing Date
2009-03-27
Accepted
2009-03-26 21:43:54
Documents
16
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2191701z10-k.htm 10-K 1326651
2 EXHIBIT 4.11 a2191701zex-4_11.htm EX-4.11 79879
3 EXHIBIT 10.25 a2191701zex-10_25.htm EX-10.25 38299
4 EXHIBIT 10.26 a2191701zex-10_26.htm EX-10.26 32162
5 EXHIBIT 10.27 a2191701zex-10_27.htm EX-10.27 31756
6 EXHIBIT 10.28 a2191701zex-10_28.htm EX-10.28 28461
7 EXHIBIT 10.29 a2191701zex-10_29.htm EX-10.29 31920
8 EXHIBIT 10.30 a2191701zex-10_30.htm EX-10.30 274613
9 EXHIBIT 23.1 a2191701zex-23_1.htm EX-23.1 3810
10 EXHIBIT 31.1 a2191701zex-31_1.htm EX-31.1 7691
11 EXHIBIT 31.2 a2191701zex-31_2.htm EX-31.2 7579
12 EXHIBIT 32.1 a2191701zex-32_1.htm EX-32.1 5460
13 G17022KO03I001.JPG g17022ko03i001.jpg GRAPHIC 1286
14 G17022KO05I001.JPG g17022ko05i001.jpg GRAPHIC 1267
15 G17022KO07I001.JPG g17022ko07i001.jpg GRAPHIC 1298
16 G403903.JPG g403903.jpg GRAPHIC 36754
  Complete submission text file 0001047469-09-003245.txt   1926249
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 (510) 585-2200
ARYx Therapeutics, Inc. (Filer) CIK: 0001410064 (see all company filings)

EIN.: 770456039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33782 | Film No.: 09707963
SIC: 2834 Pharmaceutical Preparations